Active Ingredient: Ranibizumab
• Treatment of diabetic macular edema (DME).
• Treatment of diabetic retinopathy
• Treatment of neovascular (wet) age-related macular degeneration (AMD)
• Treatment of macular edema following retinal vein occlusion (RVO)
• Treatment of myopic choroidal neovascularization (mCNV).